By analyzing DNA and proteins in the blood of people with and without acute spinal cord injuries (SCIs), researchers at the ...

The global US Biomarkers Market is expected to reach US$34.3 billion by 2029 from US$20.5 billion in 2024, at a CAGR of 10.8% ...

The automated DxC 500 I analyzer has a throughput of up to 800 clinical chemistry tests and 100 immunoassays per hour.

IF PAULA MENDES achieves her goals, her nanotechnology innovations will soon allow doctors to diagnose cancer with greater ...

The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.

The global in vitro diagnostics market (IVD) was valued at $67,111 million in 2019, and is projected to reach $91,093 million at a CAGR of 4.8% from 2020 to 2027. For instance, in clinical chemistry ...

The global coronavirus immunoassay market continues to witness steady growth, reaching USD 3.7 billion in 2021 and is projected to exceed USD 6.9 billion by 2032, expanding at a CAGR of 5.5% during ...

The global mycotoxin testing market is poised for substantial growth, with its valuation expected to rise from 𝐔𝐒𝐃 ...

There are several types of these tests. An immunoassay (IA) test is most common because it is the quickest and most cost-effective. However, IA tests can give false-positive results. In this case ...

Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama, Kanagawa 223-8522, Japan ...